Latest News and Events
Filter by
Selections
December 6, 2017
Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy
Read MoreOctober 23, 2017
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreOctober 23, 2017
Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting® 2017
Read MoreOctober 10, 2017
Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting®
Read MoreSeptember 27, 2017
Arrowhead Data Reveal Important Considerations for Future Hepatitis B Treatment
Read MoreSeptember 14, 2017